RYAM Senior Management to Present at Upcoming Boston Equity Conferences
JACKSONVILLE, Fla.--(BUSINESS WIRE)--Rayonier Advanced Materials Inc. (NYSE: RYAM) (the 'Company'), the global leader in High Purity Cellulose, announced today that senior management will participate in two upcoming equity conferences in Boston, MA.
Conference Details:
KeyBanc Capital Markets Industrials & Basic Materials Conference
Presenter: Joshua Hicks, Senior Vice President, High Purity Cellulose
Location: InterContinental Boston (510 Atlantic Ave)
1x1 Meetings: Available by request
Stifel 2025 Boston Cross Sector 1x1 Conference
Presenter: Marcus Moeltner, Chief Financial Officer and Senior Vice President, Finance
Date: June 3, 2025
Location: InterContinental Boston (510 Atlantic Ave)
1x1 Meetings: Available by request
About RYAM
RYAM is a global leader of cellulose-based technologies, including cellulose specialties, a natural polymer commonly used in the production of filters, food, pharmaceuticals and other industrial applications. RYAM's specialized assets, capable of creating the world's leading cellulose specialties products, are also used to produce commodity fluff pulp, biofuels, bioelectricity and other biomaterials such as bioethanol and tall oils. The Company also manufactures products for the paper and packaging markets. With manufacturing operations in the U.S., Canada and France, RYAM generated $1.6 billion of revenue in 2024. More information is available at www.RYAM.com.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
18 minutes ago
- Yahoo
Blackline Safety Reports Record Fiscal Second Quarter 2025 Revenue of $35.9 million and Adjusted EBITDA of $1.0 million
Record Annual Recurring Revenue (1) ("ARR") of $75.2 million, up 33% year-over-year 33rd consecutive quarter of year-over-year top-line growth 12th consecutive quarter of expanding gross margin on a rolling 12-month basis 8th consecutive quarter of Net Dollar Retention(1) ("NDR") above 125% 4th consecutive quarter of positive adjusted EBITDA(1) CALGARY, Canada, June 11, 2025--(BUSINESS WIRE)--Blackline Safety Corp. ("Blackline", the "Company", "we" or "our") (TSX: BLN), a global leader in connected safety technology, today reported its fiscal second quarter financial results for the period ended April 30, 2025. Management Commentary "Blackline has delivered another strong quarter, achieving $35.9 million in revenue for Q2 despite the dynamic macroeconomic environment," said Cody Slater, CEO and Chair of Blackline Safety. "This marks our 33rd consecutive quarter of year-over-year revenue growth, underscoring the robust market adoption of our connected safety solutions." Annual recurring revenue was up 33% year-over-year to $75.2 million. Net Dollar Retention, reflecting revenue growth from existing customers, was 128%—the 8th consecutive quarter exceeding 125%. This reinforces the sustained expansion within our customer base and the value customers place on connected safety solutions. This quarter is also the fourth consecutive quarter of positive adjusted EBITDA, further highlighting the continued strength and resilience of Blackline's proven business model. Blackline has demonstrated tremendous growth and operating leverage over the past few years — since Q2 2022 revenue has more than doubled and gross profit has increased by 220% while operating expenses have only increased by 17% over the same period. During the quarter, the Company shipped the first units of its EXO 8 Gamma area monitor, a groundbreaking device featuring radiation detection. EXO 8 is the only direct-to-cloud portable area monitor capable of detecting up to eight gases and gamma radiation at the same time. This technology strengthens Blackline's offering in the fire and hazmat and emergency response markets, opening further opportunities for growth. "Blackline's proven business model has demonstrated its resilience over the years across a variety of macroeconomic conditions. Since launching our first connected safety product in 2017, we have achieved over $500 million in sales — a clear testament to the strong adoption of our industry-pioneering product portfolio," concluded Slater. (1) This news release presents certain non-GAAP and supplementary financial measures, including key performance indicators used by management and typically used by companies in the software-as-a-service industry, as well as non-GAAP ratios to assist readers in understanding the Company's performance. Further details on these measures and ratios are included in the "Key Performance Indicators," and "Non-GAAP and Supplementary Financial Measures" sections of this news release. Financial Highlights Three-Months Ended April 30, Six-Months Ended April 30, (CAD thousands, except per share and percentage amounts) 2025 2024 % Change 2025 2024 % Change Product revenue 14,054 14,824 (5) 31,853 26,260 21 Service revenue 21,886 16,756 31 41,762 31,645 32 Total revenue 35,940 31,580 14 73,615 57,905 27 Gross profit 22,701 18,030 26 45,120 32,609 38 Gross margin percentage(1) 63% 57% 61% 56% Total expenses 25,244 21,777 16 47,702 41,693 14 Total expenses as a percentage of revenue(1) 70% 69% 65% 72% Net loss (3,704) (4,267) (13) (4,834) (10,058) (52) Loss per common share - Basic and diluted (0.04) (0.06) (33) (0.06) (0.14) (57) EBITDA(1) (301) (1,872) 84 1,755 (5,264) NM EBITDA per common share(1) - Basic and diluted 0.00 (0.03) NM 0.02 (0.07) NM Adjusted EBITDA(1) 1,040 (2,043) NM 2,557 (5,278) NM Adjusted EBITDA per common share(1) - Basic and diluted 0.01 (0.03) NM 0.03 (0.07) NM (1) Refer to "Non-GAAP and Supplementary Financial Measures" at the end of this document for further detail. NM – Not meaningful Fiscal Second Quarter 2025 and Recent Financial and Operational Highlights Blackline reported total revenue of $35.9 million, a 14% year-over-year increase. This growth was driven by a 31% increase in service revenue to $21.9 million, reflecting robust demand for Blackline's connected software services, which increased 32% to $19.2 million, along with rentals, which grew 20% to $2.7 million. Second quarter product revenue declined 5% year-over-year. This pullback was driven by geopolitical uncertainty that delayed deals in North America and internationally. While this timing impacts quarter-over-quarter comparability, product revenue increased 21% for the first half of 2025 compared to the same period in the previous year, underscoring the strength of our continued momentum into the second half of the year. From a regional performance perspective, the Rest of World achieved a notable increase, with revenue advancing by 78% in the second quarter relative to the same period in the prior year. This robust growth affirms the continued expansion of our sales network and targeted initiatives in key areas such as the Middle East. In Canada and Europe, revenue increased by 23% and 14% respectively. Meanwhile, the U.S. market experienced a modest 1% increase, reflecting investment slowdown. Gross margin reached a record of 63%, up from 57% in the prior year's quarter, driving gross profit for the second quarter up 26% year-over-year to $22.7 million. Service gross margin reached a record 79%, reflecting the Company's high-margin recurring revenue and growing demand for its connected safety services. Product gross margin was 39%, up from 34% a year ago, highlighting the resilience of Blackline's hardware margins despite tariff headwinds in the quarter. Trailing 12-month gross margin climbed to 61%, marking the 12th consecutive quarter of margin expansion. Total expenses were 70% as a percentage of revenue – compared with 69% last year in Q2 – as Blackline continued to invest in its operational infrastructure and sales growth initiatives. General and administrative expenses were 23% of revenue this year, compared to 21% in Q2 2024, driven by investments to support the Company's previously disclosed scalability initiatives. Sales and marketing expenses declined to 32% of revenue from 33% last year. Product research and development expenses decreased to 15% as a percentage of revenue from 16%. Adjusted EBITDA for the quarter was $1.0 million, a significant improvement from a ($2.0) million loss in the prior year's quarter. This marks the fourth consecutive quarter of positive adjusted EBITDA, demonstrating the increasing scalability and resilience of Blackline's business model. The adjustment to EBITDA this quarter includes certain tariffs imposed on inventory shipped to the United States. Net loss for the quarter narrowed to ($3.7) million, a 13% improvement from Q2 last year, reflecting higher gross profit and improved operational leverage. Blackline's cash and short-term investments totaled $52.6 million at the end of the quarter, a 22% increase from year-end fiscal 2024. The securitization facility was fully paid down and not renewed during the quarter. The Company had available capacity on its senior secured operating facility, including its accordion feature, of $17.5 million as of April 30, 2025, for total available liquidity of $70.1 million. Blackline's Interim Condensed Consolidated Financial Statements and Management's Discussion and Analysis on Financial Condition and Results of Operations for the three-month and six-month period ended April 30, 2025, are available on SEDAR+ under the Company's profile at All results are reported in Canadian dollars. Outlook Most of the Company's products are United States–Mexico–Canada Agreement ("USMCA") compliant and exempt from tariffs currently in place on goods shipped to the United States from Canada. As a result, Blackline Safety remains well-positioned to expand its business with its comprehensive suite of connected safety wearables and area monitors. The Company's technology supports diverse industries worldwide, delivering real-time safety insights, emergency response management, and improved productivity. The uncertainty surrounding tariffs may slow the global investment environment and impose additional costs on the business, with potential negative impacts on revenue and earnings. Blackline remains committed to leveraging its innovative product portfolio to meet the needs of customers worldwide. With strategic investments in manufacturing, sales, and marketing, we will continue to drive strong growth, particularly in our high margin service revenue, as we help transform the industrial workplace into a connected one. Conference Call A conference call and live webcast have been scheduled for 11:00 am ET on Wednesday, June 11, 2025. Participants should dial 1-833-821-3052 or 1-647-846-2509 at least 10 minutes prior to the conference time. A live webcast will also be available at Participants should join the webcast at least 10 minutes prior to the start time to register and install any necessary software. A replay will be available after 2:00 PM ET on June 11, 2025 through July 11, 2025 by dialling 1-855-669-9658 (Canada/USA Toll Free) or 1-412-317-0088 (International Toll) and entering access code 3417383. About Blackline Safety: Blackline Safety is a technology leader driving innovation in the industrial workforce through IoT (Internet of Things). With connected safety devices and predictive analytics, Blackline enables companies to drive towards zero safety incidents and improved operational performance. Blackline provides wearable devices, personal and area gas monitoring, cloud-connected software and data analytics to meet demanding safety challenges and enhance overall productivity for organizations with customers in more than 75 countries. Armed with cellular and satellite connectivity, Blackline provides a lifeline to tens of thousands of people, having reported over 286 billion data-points and initiated over eight million emergency alerts. For more information, visit and connect with us on Facebook, X (formerly Twitter), LinkedIn and Instagram. Non-GAAP and Supplementary Financial Measures This press release presents certain non-GAAP and supplementary financial measures, including key performance indicators used by management typically used by the Company's competitors in the software-as-a-service industry, as well as non-GAAP ratios to assist readers in understanding the Company's performance. These measures do not have any standardized meaning and therefore are unlikely to be comparable to similar measures presented by other issuers and should not be considered in isolation or as a substitute for measures of performance prepared in accordance with GAAP. Management uses these non-GAAP and supplementary financial measures, as well as non-GAAP ratios and key performance indicators to analyze and evaluate operating performance. Blackline also believes the non-GAAP and supplementary financial measures defined below are commonly used by the investment community for valuation purposes, and are useful complementary measures of profitability, and provide metrics useful in Blackline's industry. Throughout this news release, the following terms are used, which do not have a standardized meaning under GAAP. Key Performance Indicators The Company recognizes service revenues ratably over the term of the service period under the provisions of agreements with customers. The terms of agreements, combined with high customer retention rates, provides the Company with a significant degree of visibility into near-term revenues. Management uses several metrics, including the ones identified below, to measure the Company's performance and customer trends, which are used to prepare financial plans and shape future strategy. Key performance indicators may be calculated in a manner different than similar key performance indicators used by other companies. See also "Supplementary Financial Measures" below. "Annual Recurring Revenue" is the total annualized value of recurring service amounts (ultimately recognized as software services revenue) of all service contracts at a point in time. Annualized service amounts are determined solely by reference to the underlying contracts, adjusting for the varying revenue recognition treatments under IFRS 15 Revenue from Contracts with Customers. It excludes one-time fees, such as for rentals, non-recurring professional services, and assumes that customers will renew the contractual commitments on a periodic basis as those commitments come up for renewal, unless such renewal is known to be unlikely. We believe that ARR provides visibility into future cash flows and is a fair measure of the performance and growth of our service contracts. "Net Dollar Retention" compares the aggregate service revenue contractually committed for a full period under all customer agreements of our total customer base as of the beginning of the trailing twelve-month period to the total service revenue of the same group at the end of the period. It includes the effect of our service revenue that expands, renews, is upsold or downsold or cancelled, but excludes the total service revenue from new activations during the period. We believe that NDR provides a fair measure of the strength of our recurring revenue streams and growth within our existing customer base. Non-GAAP Financial Measures A non-GAAP financial measure: (a) depicts the historical or expected future financial performance, financial position or cash of the Company; (b) with respect to its composition, excludes an amount that is included in, or includes an amount that is excluded from, the composition of the most comparable financial measure presented in the primary consolidated financial statements; (c) is not presented in the primary financial statements of the Company; and (d) is not a ratio. Non-GAAP financial measures presented and discussed in this news release are as follows: "EBITDA" is useful to securities analysts, investors and other interested parties in evaluating operating performance by presenting the results of the Company which excludes the impact of certain non-cash or non-operational items. EBITDA is calculated as earnings before interest expense, interest income, income taxes, depreciation and amortization. "Adjusted EBITDA" is useful to securities analysts, investors and other interested parties in evaluating operating performance by presenting the results of the Company which excludes the impact of certain non-operational items and certain non-cash and non-recurring items, such as stock-based compensation expense. Adjusted EBITDA is calculated as earnings before interest expense, interest income, income taxes, depreciation and amortization, stock-based compensation expense, foreign exchange loss (gain), and non-recurring impact transactions, if any. The Company considers an item to be non-recurring when a similar revenue, expense, loss or gain is not reasonably likely to occur. Reconciliation of non-GAAP financial measures Three-Months Ended April 30, Six-Months Ended April 30, (CAD thousands) 2025 2024 % Change 2025 2024 % Change Net loss (3,704) (4,267) (13) (4,834) (10,058) (52) Depreciation and amortization 2,242 1,875 20 4,337 3,820 14 Finance (income) expense, net (177) 279 NM (68) 465 NM Income tax expense 1,338 241 455 2,320 509 356 EBITDA (301) (1,872) 84 1,755 (5,264) NM Stock-based compensation expense(1) 994 377 164 1,449 729 99 Foreign exchange gain (4) (548) (99) (1,198) (743) 61 Other non-recurring impact transactions(2) 351 — NM 551 — NM Adjusted EBITDA 1,040 (2,043) NM 2,557 (5,278) NM (1) Stock-based compensation expense relates to the Company's stock compensation plan and stock option expense is extracted from cost of sales, general and administrative expenses, sales and marketing expenses and product research and development costs on the condensed consolidated statements of loss and comprehensive loss. (2) Other non-recurring impact transactions in the current quarter includes tariffs imposed on inventory shipped to the United States and severance costs relating to the departure of a senior management personnel during the prior quarter. NM – Not meaningful Non-GAAP Ratios A non-GAAP ratio is a financial measure presented in the form of a ratio, fraction, percentage or similar representation and that has a non-GAAP financial measure as one or more of its components. Non-GAAP ratios presented and discussed in this news release are as follows: "EBITDA per common share" is useful to securities analysts, investors and other interested parties in evaluating operating and financial performance. EBITDA per common share is calculated on the same basis as net income (loss) per common share, utilizing the basic and diluted weighted average number of common shares outstanding during the periods presented. "Adjusted EBITDA per common share" is useful to securities analysts, investors and other interested parties in evaluating operating and financial performance. Adjusted EBITDA per common share is calculated on the same basis as net income (loss) per common share, utilizing the basic and diluted weighted average number of common shares outstanding during the periods presented. Supplementary Financial Measures A supplementary financial measure: (a) is, or is intended to be, disclosed on a periodic basis to depict the historical or expected future financial performance, financial position or cash flow of the Company; (b) is not presented in the financial statements of the Company; (c) is not a non-GAAP financial measure; and (d) is not a non-GAAP ratio. Supplementary financial measures presented and discussed in this news release is as follows: "Gross margin percentage" represents gross margin as a percentage of revenue "Annual Recurring Revenue" represents total annualized value of recurring service amounts of all service contracts "Net Dollar Retention" represents the aggregate service revenue contractually committed "Product gross margin percentage" represents product gross margin as a percentage of product revenue "Service gross margin percentage" represents service gross margin as a percentage of service revenue "Total expenses as a percentage of revenue" represents total expenses as a percentage of total revenue Note Regarding Forward Looking Statements This news release contains forward-looking statements and forward-looking information (collectively "forward-looking information") within the meaning of applicable securities laws relating to, among other things, the Company's expectation that EXO 8 provides an opening further opportunities for growth, management's belief that the current macroeconomic uncertainty is temporary, that the Company believes a majority its products are USMCA compliant and exempt from tariffs currently in place for goods being shipped to the United States from Canada and that the Company is well-positioned to expand its business with its comprehensive suite of connected safety wearables and area monitors, that the Company will continue to drive strong growth, especially in its high margin service revenue. Blackline provided such forward-looking statements in reliance on certain expectations and assumptions that it believes are reasonable at the time. The material assumptions on which the forward-looking information in this news release are based, and the material risks and uncertainties underlying such forward-looking information, include: expectations and assumptions concerning business prospects and opportunities, customer demands, the availability and cost of financing, labor and services, that Blackline will pursue growth strategies and opportunities in the manner described herein, and that it will have sufficient resources and opportunities for the same, that other strategies or opportunities may be pursued in the future, and the impact of increasing competition, business and market conditions; the accuracy of outlooks and projections contained herein; the continuation of USMCA and other applicable trade agreements; that future business, regulatory, and industry conditions will be within the parameters expected by Blackline, including with respect to prices, margins, demand, supply, product availability, supplier agreements, availability, and cost of labour and interest, exchange, and effective tax rates; projected capital investment levels, the flexibility of capital spending plans, and associated sources of funding; cash flows, cash balances on hand, and access to the Company's credit facility being sufficient to fund capital investments; foreign exchange rates; near-term pricing and continued volatility of the market; accounting estimates and judgments; the ability to generate sufficient cash flow to meet current and future obligations; the Company's ability to obtain and retain qualified staff and equipment in a timely and cost-efficient manner; the Company's ability to carry out transactions on the desired terms and within the expected timelines; forecast inflation, including on the Company's components for its products, regulatory changes, supply chain disruptions, macroeconomic conditions, US-Canada tariffs, the impacts of the military conflict between Russia and Ukraine and between Israel and Hamas on the global economy; and other assumptions, risks, and uncertainties described from time to time in the filings made by Blackline with securities regulatory authorities. Although Blackline believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because Blackline can give no assurance that they will prove to be correct. Forward-looking information addresses future events and conditions, which by their very nature involve inherent risks and uncertainties, including the risks set forth above and as discussed in Blackline's Management's Discussion and Analysis and Annual Information Form for the year ended October 31, 2024 and available on SEDAR+ at Blackline's actual results, performance or achievement could differ materially from those expressed in, or implied by, the forward-looking information and, accordingly, no assurance can be given that any of the events anticipated by the forward-looking information will transpire or occur, or if any of them do so, what benefits Blackline will derive therefrom. Management has included the above summary of assumptions and risks related to forward-looking information provided in this press release in order to provide readers with a more complete perspective on Blackline's future operations and such information may not be appropriate for other purposes. Readers are cautioned that the foregoing lists of factors are not exhaustive. These forward-looking statements are made as of the date of this press release and Blackline disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws. View source version on Contacts INVESTOR/ANALYST CONTACT Jason Zandberg, Director, Investor Relations jzandberg@ Telephone: +1 587 324 9184 MEDIA CONTACT Jodi Stapley, Director, Brand jstapley@ Telephone: +1 587-355-5907
Associated Press
18 minutes ago
- Associated Press
Rafael Holdings Reports Third Quarter Fiscal 2025 Financial Results
NEWARK, N.J., June 11, 2025 (GLOBE NEWSWIRE) -- Rafael Holdings, Inc. (NYSE: RFL; NYSE American: RFL-WT), today reported its financial results for the third quarter and first nine months of fiscal year 2025 ended April 30, 2025. 'We are pleased to have completed our merger with Cyclo Therapeutics and look forward to reporting the topline data from the 48-week interim analysis of the pivotal Phase 3 TransportNPC ™ study evaluating Trappsol® Cyclo™ for the treatment of Niemann-Pick Disease Type C1 anticipated later this month,' said Howard Jonas, Chief Executive Officer, Executive Chairman and Chairman of the Board of Rafael Holdings. Mr. Jonas added, 'We have enhanced our financial position with the closing of a $25 million rights offering earlier this month which will support advancing this potential new treatment option for patients suffering from this rare genetic disease.' Rafael Holdings, Inc. Third Quarter Fiscal Year 2025 Financial Results As of April 30, 2025, we had cash and cash equivalents of $37.9 million. On June 4, 2025, the Company announced the closing of a $25 million rights offering, which, including the funding of the backstop commitment by the Jonas family, raised net proceeds of $24.9 million after deduction of certain expenses incurred in connection with the offering. For the three months ended April 30, 2025, we recorded a net loss attributable to Rafael Holdings of $4.8 million, or $0.19 per share, versus a net loss of $32.4 million, or $1.36 per share in the year ago period. The year over year decrease in net loss is attributable to non-cash items, primarily unrealized losses of $1.4 million on the Company's investment in Cyclo equity which we purchased in advance of the potential merger in the current period versus $4.4 million in the year ago period, combined with an in-process R&D expense of $89.9 million related to the acquisition of Cornerstone, partially offset by a $31.3 million recovery of receivables from Cornerstone in the year ago period. Research and development expenses were $3.0 million for the three months ended April 30, 2025, compared to $1.5 million in the year ago period. The year over year increase relates to the inclusion in the current year period of spending at Cyclo Therapeutics following the March 25, 2025 merger and the activity of Cornerstone and Day Three which were consolidated with Rafael Holdings during fiscal 2024. General and administrative expenses were $3.2 million for the three months ended April 30, 2025, compared to $1.9 million in the year ago period. The year over year increase relates to the inclusion of Cyclo Therapeutics following closing of the merger, and the activity of Cornerstone and Day Three, following their consolidation. Rafael Holdings, Inc. First Nine Months Fiscal Year 2025 Financial Results For the nine months ended April 30, 2025, we recorded a net loss attributable to Rafael Holdings of $18.4 million, or $0.73 per share, versus a net loss of $29.9 million, or $1.26 per share in the year ago period. The year over year decrease in net loss is attributable to in-process R&D expense of $89.9 million related to the acquisition of Cornerstone net with a $31.3 million recovery of receivables from Cornerstone in the year ago period and $3.2 million in unrealized gains on the Company's investment in Cyclo equity. Research and development expenses were $5.3 million for the nine months ended April 30, 2025, compared to $2.6 million in the year ago period. The year over year increase relates to the merger with Cyclo Therapeutics which closed on March 25, 2025, and the activity of Cornerstone and Day Three, which were consolidated with Rafael Holdings during fiscal 2024. For the nine months ended April 30, 2025, general and administrative expenses were $8.3 million compared to $6.5 million in the same period in the prior year. The year over year increase relates to the merger with Cyclo Therapeutics which closed on March 25, 2025, and the activity of Cornerstone and Day Three, which were consolidated with Rafael Holdings during fiscal 2024. About Rafael Holdings, Inc. Rafael Holdings, Inc. holds interests in clinical and early-stage pharmaceutical and certain other companies, including our wholly owned subsidiary, Cyclo Therapeutics, LLC, a clinical stage biotechnology company dedicated to developing Rafael's lead clinical candidate, Trappsol® Cyclo™, which is being evaluated in clinical trials for the potential treatment of Niemann-Pick Disease Type C1 ('NPC1'), a rare, fatal, and progressive genetic disorder. Rafael also holds majority equity interests in LipoMedix Pharmaceuticals Ltd., a clinical stage pharmaceutical company, Cornerstone Pharmaceuticals, Inc., formerly known as Rafael Pharmaceuticals Inc., a cancer metabolism-based therapeutics company, Rafael Medical Devices, LLC, an orthopedic-focused medical device company developing instruments to advance minimally invasive surgeries, and Day Three Labs, Inc., a company which empowers third-party manufacturers to reimagine their existing cannabis offerings. Forward Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements, including without limitation statements regarding our expectations surrounding the potential, safety, efficacy, and regulatory and clinical progress of our product candidates; plans regarding the further evaluation of clinical data; and the potential of our pipeline, including our internal cancer metabolism research programs. These statements are neither promises nor guarantees, but involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including, but not limited to, those disclosed under the caption 'Risk Factors' in our Annual Report on Form 10-K for the year ended July 31, 2024, and our other filings with the SEC. These factors could cause actual results to differ materially from those indicated by the forward-looking statements made in this press release. Any such forward-looking statements represent management's estimates as of the date of this press release. While we may elect to update such forward-looking statements at some point in the future, we disclaim any obligation to do so, even if subsequent events cause our views to change. Contact: Barbara Ryan [email protected] (203) 274-2825
Associated Press
18 minutes ago
- Associated Press
EBC Financial Group Launches over a 100 U.S. ETF CFDs, Strengthening Diversification for Global Clients
LONDON, June 11, 2025 (GLOBE NEWSWIRE) -- EBC Financial Group (EBC) has announced the launch of over 100 new U.S.-listed Exchange-Traded Fund (ETF) CFDs, expanding its multi-asset product suite and offering global client's deeper access to diversified, thematic trading opportunities. The rollout highlights EBC's ongoing commitment to delivering institutional-grade tools across asset classes, underpinned by flexibility, transparency, and efficiency. The new offering includes ETFs listed on the NYSE and NASDAQ, issued by leading asset managers such as Vanguard, iShares (BlackRock), and State Street Global Advisors. Thematic coverage spans a wide range of global macro and sectoral narratives. 'This expansion reflects our vision to bridge intelligent product design with market relevance,' said David Barrett, CEO of EBC Financial Group (UK) Ltd. 'The new products are a natural evolution for traders seeking targeted exposure with greater strategic flexibility. At EBC, we're building an ecosystem that empowers both precision and performance.' Thematic Access Meets Tactical Flexibility The additional ETF-linked instruments cover a variety of market exposures, including geographic allocations like the iShares MSCI Brazil ETF; fixed income-focused strategies such as the iShares iBoxx $ High Yield Corporate Bond Fund; and sector- or commodity-based indices including the United States Oil Fund LP and the Vanguard Health Care ETF. Other themes include dividend-related baskets, mid-cap equities, and style-based index tracking. These developments reflect wider industry interest in instruments that mirror trends in asset allocation without direct ownership of the underlying securities. Across many markets, sector-tilted and style-based index products are gaining relevance as participants seek flexible ways to align with global narratives. Historically, ETFs tracking specific economic cycles—such as commodity recoveries or emerging market rebounds—have demonstrated performance differentiation. The iShares MSCI Brazil ETF, for example, notably outperformed the S&P 500 during the post-pandemic recovery period in 2021, highlighting how thematic instruments can diverge from broad indices depending on market cycles. These additions serve as both stand-alone trade ideas and complementary instruments alongside EBC's existing product lineup, enabling advanced portfolio structuring and thematic trading. Smarter Exposure: Leverage, Shorting, and Cost Efficiency in One Product Compared to direct ETF investments, it presents several key advantages as traders benefit from a simplified cost structure, with no traditional fund management fees or broker commissions. The flexibility to take both long and short positions allows for strategic trading regardless of market direction, while the use of leverage enhances capital efficiency and return potential. These trades are executed in real time via EBC's recognised platforms, providing seamless access to market opportunities. During key market cycles, for example the post-pandemic V-shaped recovery of 2021—certain thematic ETFs, like the iShares MSCI Brazil ETF, significantly outperformed broader indices such as the S&P 500. Our portfolio enables traders to participate in similar trends, adapting quickly to shifting market dynamics with precision and speed. Getting Started These products can be accessed by registering on to begin simulated or live trading. About EBC Financial Group Founded in London's esteemed financial district, EBC Financial Group (EBC) is a global brand known for its expertise in financial brokerage and asset management. Through its regulated entities operating across major financial jurisdictions—including the UK, Australia, the Cayman Islands, Mauritius, and others—EBC enables retail, professional, and institutional investors to access a wide range of global markets and trading opportunities, including currencies, commodities, shares, and indices. Recognised with multiple awards, EBC is committed to upholding ethical standards and is licensed and regulated within the respective jurisdictions. EBC Financial Group (UK) Limited is regulated by the UK's Financial Conduct Authority (FCA); EBC Financial Group (Cayman) Limited is regulated by the Cayman Islands Monetary Authority (CIMA); EBC Financial Group (Australia) Pty Ltd, and EBC Asset Management Pty Ltd are regulated by Australia's Securities and Investments Commission (ASIC); EBC Financial (MU) Ltd is authorised and regulated by the Financial Services Commission Mauritius (FSC). At the core of EBC are a team of industry veterans with over 40 years of experience in major financial institutions. Having navigated key economic cycles from the Plaza Accord and 2015 Swiss franc crisis to the market upheavals of the COVID-19 pandemic. We foster a culture where integrity, respect, and client asset security are paramount, ensuring that every investor relationship is handled with the utmost seriousness it deserves. As the Official Foreign Exchange Partner of FC Barcelona, EBC provides specialised services across Asia, LATAM, the Middle East, Africa, and Oceania. Through its partnership with United to Beat Malaria, the company contributes to global health initiatives. EBC also supports the 'What Economists Really Do' public engagement series by Oxford University's Department of Economics, helping to demystify economics and its application to major societal challenges, fostering greater public understanding and dialogue. Media Contact: Savitha Ravindran Global Public Relations Manager s[email protected] Michelle Siow Brand & Communications Director [email protected]
